Compare Taskus Inc (TASK) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Taskus Inc vs UnitedHealth Group Inc — how do they compare? Taskus Inc trades at $6.91 (market cap $650.52M), while UnitedHealth Group Inc trades at $402.6 (market cap $371.19B). The key difference: UnitedHealth Group Inc is far larger — about 570.6× Taskus Inc's market cap, and UnitedHealth Group Inc pays a 2.27% dividend while Taskus Inc pays none. Which is the better fit depends on your goals.
| TASK | UNH | |
|---|---|---|
Market Cap | $650.52M | $371.19B |
Sector | Technology | Health |
52-Week High | $18.21 | $436.35 |
52-Week Low | $4.57 | $252.37 |
Enterprise Value | $1.02B | $417.88B |
Dividend Yield | — | 2.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TaskUs (TASK) trades at $7.30, down 6.65% today, but maintains strong fundamentals with Q2 2026 revenue beating guidance by $10.9 million. The stock shows bullish technical signals with support at $7 and bullish moving averages. Valuation metrics appear attractive with P/E of 6.29 and P/S of 0.55, while profitability remains solid with 8.75% net margin and 25.43% ROE. Recent CFO appointment and AI services growth provide positive catalysts.
The outlook remains positive with analyst consensus favoring Buy ratings (54.55%) and improving cash flow trends. Key opportunities include undervaluation relative to earnings power and AI services expansion. Risks include client concentration and potential earnings volatility. The combination of reasonable valuation and growth momentum supports a constructive view for patient investors.
UnitedHealth Group (UNH) trades at $407.08, up 0.77% on the day, with a bearish technical signal but strong analyst consensus. Recent earnings beats in Q1 and Q2 2026 highlight operational strength, though net income margin has compressed to 2.68% in 2025. The company is reducing pediatric prior authorizations to improve care access, amid regulatory scrutiny from a Massachusetts Medicaid lawsuit.
The outlook remains positive with an 82.69% buy rating from analysts and a $476.50 consensus price target, suggesting 17% upside. Key risks include regulatory pressures and margin pressures, but aging demographics and tech innovation in healthcare support long-term growth. Cash flow generation funds dividends and buybacks, reinforcing shareholder returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
